The National Institute of Allergy and Infectious Diseases (NIAID) has
launched a clinical trial to evaluate an experimental treatment for patients
infected with West Nile virus (http://www.niaid.nih.gov/newsroom/releases/wnv_trials.htm). Through the trial, researchers hope to assess whether giving infected
individuals immunoglobulin containing antibodies to West Nile virus can reduce
the severity of illness.
Hampton T. Avoiding Medical Errors. JAMA. 2003;290(16):2117. doi:10.1001/jama.290.16.2117-a